Cypher Genomics' Mantis
Cypher Genomics has released a new software update to automate the interpretation of sequencing data from cancer genomes. With the update, Cypher's Mantis technology will now provide rapid insight into how different genetic variants may impact cancer progression and therapeutic effectiveness, the company said. The update will also provide a summary of somatic and germline variants for single nucleotide variants and small indels, as well as resolve difficult-to-classify variants of unknown significance.